TVGN
Tevogen Bio Holdings Inc.

2,735
Loading...
Loading...
News
all
press releases
Buy When There’s Blood in the Streets: Why the DeepSeek Rout May Be Good News for Microsoft Stock
Microsoft’s stock presents a buying opportunity due to its strong financials, strategic partnerships, and potential to benefit from cheaper AI models in the long run.
barchart.com·7mo ago
News Placeholder
More News
News Placeholder
Tevogen Bio Shares Surge After AI Tie-Up With Microsoft: Retail Turns Bullish
The partnership marks a “significant milestone” to lower the total cost of drug development, the company said.
Stocktwits·11mo ago
News Placeholder
Why Tevogen Bio Holdings Stock Is Moving Higher Today
Tevogen shares are rising Monday after the company secured up to $50 million of financing from an existing investor aimed at supporting continued research and development efforts for Tevogen's TVGN...
Benzinga·1y ago
News Placeholder
12 acciones de salud en movimiento durante la preapertura del 04/04/2024
Acciones al alza Tevogen Bio Holdings (NASDAQ:TVGN) ganaron un 92,75% para establecerse en los 5,05 d lares durante la sesi n del pre-market del jueves. Candel Therapeutics (NASDAQ:CADL) avanzaron un...
Benzinga·1y ago
News Placeholder
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of...
Globe Newswire·1y ago
News Placeholder
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
WARREN, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically...
Globe Newswire·1y ago
News Placeholder
Tevogen Bio Announces Series A-1 Preferred Stock Investment
WARREN, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically...
Globe Newswire·1y ago
News Placeholder
Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), today announced TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+ T lymphocytes (CTLs) immunotherapy for treatment of...
Business Wire·1y ago
News Placeholder
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita
Tevogen Bio Holdings ('Tevogen Bio') (Nasdaq: TVGN), congratulates Victor Sordillo PE, CSP, MBA, on his recent appointment as Managing Director of Risk Advisory Services at Verita CSG, Inc., a...
Business Wire·2y ago
News Placeholder
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI
Tevogen Bio Holdings Tevogen (Nasdaq: TVGN) Chief Information Officer and Head of companys Artificial Intelligence Initiative, Tevogen.ai, Mittul Mehta, has taken strides to emphasize the importance...
Business Wire·2y ago

Latest TVGN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.